PMC:7755033 / 31010-31281 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"522","span":{"begin":75,"end":85},"obj":"Chemical"},{"id":"523","span":{"begin":90,"end":100},"obj":"Chemical"},{"id":"532","span":{"begin":183,"end":185},"obj":"Species"},{"id":"533","span":{"begin":250,"end":258},"obj":"Chemical"}],"attributes":[{"id":"A522","pred":"tao:has_database_id","subj":"522","obj":"MESH:D000069449"},{"id":"A523","pred":"tao:has_database_id","subj":"523","obj":"MESH:C557213"},{"id":"A532","pred":"tao:has_database_id","subj":"532","obj":"Tax:126910"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ts exhibited Lipinski’s violation. Interestingly, standard reference drugs cinacalcet and poziotinib displayed 1 violation each of Lipinski’s rule of five.\nTable 2. PASS analysis of WS phytoconstituents versus FDA-approved standard reference drugs (Losartan, Procainamid"}

{"project":"LitCovid-sentences","denotations":[{"id":"T269","span":{"begin":35,"end":155},"obj":"Sentence"},{"id":"T270","span":{"begin":156,"end":164},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ts exhibited Lipinski’s violation. Interestingly, standard reference drugs cinacalcet and poziotinib displayed 1 violation each of Lipinski’s rule of five.\nTable 2. PASS analysis of WS phytoconstituents versus FDA-approved standard reference drugs (Losartan, Procainamid"}